top of page
.png)
About Us
How we think and what we invest in
AI is already great at recognizing patterns that allow for care to be better. But how do you develop technologies that follow the technology curve of dropping cost while improving quality? What is noise and what is signal? What are the methods of addressing this that are a step-function better than what we have AND use today? How do we get people to adopt and adapt to better methodologies? And how do we leverage the march of technology to lower costs such that ALL people have access?
Many technologies and patterns that are relevant to healthcare are not borne of healthcare, but could be applied. That is why P5 has a “primary focus” on healthcare. Further, our view of what healthcare is has always been much broader than our current healthcare system, which effectively ignores nutrition and the metabolic causes of disease. We have long written to our investors of the value of doing everything you can to be healthier. This concept of wellness (nutrition, environment, psychology, etc.) as part of medicine has existed for thousands of years. Western medicine is finally being forced to re-embrace it as the data of its value becomes overwhelming, particularly for chronic diseases such as all autoimmune diseases and cancers, which we focus on.
This does not in any way mean replacing modern medicine. Rather, it is to embrace all options and couple AI with human experience and intuition to build treatment models. In true “healthcare,” all options should be on the table and the risks to each patient should be readily discerned and chosen.
Our strategy is to anticipate the march of technology (clear patterns long exist) and invest in great entrepreneurs who can leverage that technology (AI helping interpret diagnostics, symptom-ology, epidemiology, etc.) to discern patterns and guide treatment. Only with this technology-enabled ability can we dramatically lower the cost of infinitely better care. And that is where we focus.
Lastly, we invest in companies that can save people very soon, and preferably now. Then from those platforms we want to see continuous innovation to be better and more accessible with each passing day.
Mission
Enable the prevention of and healing from chronic and infectious diseases, ending misery and saving lives.​
Vision
Create the platform with minority and majority ownership positions in technologies working individually and collectively to solve complex health problems, better and faster than any other solution.​
Philosophy
The human body and the environments we create and live in are complex interactive systems that cannot be isolated for healing, sustainable health and longevity. Everyone deserves to be healthy and have an extended healthspan. Technology must march through healthcare, enabling costs to decline and health to increase.​
Areas of interest
-
Diagnostics
-
Biomarkers
-
Chronic disease management, including autoimmune, cancer and behavioral health​
​
-
Digital twins
-
AI - decision support
-
Consumer driven healthcare, including nutrition, lifestyle and wellness
​
-
Longevity
-
Population health management, value based care
Other areas of our interest include technologies that will drive down the cost of care and make high-quality healthcare accessible for all. We are very focused on those that increase accessibility and create significant savings in cost AND price.
Round
P5HV is primarily focused on Seed - Series B companies that are near revenue generation (<18 months) or currently have revenues and clear exit paths.
Team
David Eigen
bottom of page